retatrutide phase 3 trials The numbers from Lilly's trial dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Retatrutide Achieves Up to 30.3%

Seek same-day medical advice or attend A&E if you develop: Severe hypoglycaemia requiring assistance from another person, loss of consciousness, or seizures Diabetic ketoacidosis symptoms : excessive thirst, frequent urination, fruity-smelling breath, confusion, or rapid breathing (though less common in type 2 diabetes, it can occur) Severe abdominal pain that is persistent and may indicate pancreatitis or gallbladder disease Signs of severe dehydration : dizziness, reduced urine output, confusion, or rapid heartbeat Allergic reactions : difficulty breathing, facial swelling, or widespread rash Routine situations that warrant scheduled contact include: Planning pregnancy or discovering you are pregnant, as both medications require specialist review and potential adjustment Scheduling surgery or procedures requiring fasting, as medication timing and doses need modification Starting new medications that may interact with glucose control (such as corticosteroids, certain antibiotics, or other diabetes medications) Experiencing persistent gastrointestinal side effects that affect your quality of life or ability to maintain adequate nutrition Noticing unexplained weight loss beyond expected effects, persistent fatigue, or other concerning symptoms DVLA and driving advice: If you are taking insulin, you must inform the DVLA

recommended dose 2 mg SC daily for HIV lipodystrophy PubMed Ipamorelin, the first selective growth hormone secretagogue High GH potency and selectivity

This is where pharmacists transform safety from theory into real patient protection

Allan says

Triple-receptor agonist of GLP-1, GIP, and glucagon pathways